Mitzi Joi Williams, MD, FAAN, medical director and CEO of Joi Life Wellness Neurology Clinic, discusses how underrepresentation of minority population patients in clinical trials became an issue and how education and raising awareness can begin to remedy it.
Mitzi Joi Williams, MD, FAAN, medical director and CEO of Joi Life Wellness Neurology Clinic, discusses how underrepresentation of minority population patients in clinical trials became an issue and how education and raising awareness can begin to remedy it. She sat down for this interview as part of our coverage of this year’s American Academy of Neurology Annual Meeting.
Transcript
How can clinicians effectively partner with underrepresented communities to better their participation in MS trials?
Underrepresentation in clinical trials is a huge issue, not just with multiple sclerosis [MS], but really with all areas of disease, even ones that occur very commonly in these populations, such as diabetes, heart disease, etc. I think that we got here because many of our trials are conducted globally, particularly with multiple sclerosis, because the incidence hadn't been recognized as so high in these populations. Most of our trials are conducted in Eastern Europe, where we know there's a very high prevalence of multiple sclerosis. So I think we got here because we were going to populations where we know MS occurs, and patients can enroll in trials very quickly.
I think that the way we overcome this is first recognizing that this is a problem. And I think that it's important for industry partners, as well as medical facilities, academic centers, even private practice MS centers, to partner with the community with trusted voices to raise awareness about the importance of participation in clinical research, to educate the public about clinical research, but also to ask people to be involved in trials and not assume that they don't want to be involved. I think that when we add all of those efforts together we will begin to see a change in the demographics of our clinical research.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Health Equity and Access Weekly Roundup: March 23, 2024
March 23rd 2024The Center on Health Equity and Access covered disparities in hypertension, diabetic eye health, and hidradenitis suppurativa, along with the proposed legislation banning diversity, equity, and inclusion efforts in Alabama schools and the consequences in sickle cell care from the CDC guideline for opioid prescriptions.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Low Screening Rates for Lung Cancer Highlight Public Health Priority
March 21st 2024Overall rates for lung cancer screening remain low, despite the US Preventive Services Task Force revising its annual screening recommendation in 2021 by lowering the age of initial screening for current or former smokers and their pack-year history.
Read More